Detalhe da pesquisa
1.
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.
Virol J
; 12: 4, 2015 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623235
2.
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
Clin Infect Dis
; 58(11): 1549-53, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24633686
3.
Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver.
Clin Infect Dis
; 56(4): 560-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23090932
4.
Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients.
Clin Infect Dis
; 56(8): 1117-22, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23315321
5.
Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain.
Liver Int
; 33(9): 1357-62, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23730876
6.
Update on HIV/HCV coinfection.
Curr HIV/AIDS Rep
; 10(3): 226-34, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23832718
7.
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes.
J Infect Dis
; 205(3): 376-83, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22158703
8.
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.
J Infect Dis
; 206(6): 961-8, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22807523
9.
Management and treatment of chronic hepatitis C in HIV patients.
Semin Liver Dis
; 32(2): 138-46, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22760653
10.
Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.
Clin Infect Dis
; 55(1): e1-4, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22460962
11.
Pharmacogenetics of hepatitis C.
J Antimicrob Chemother
; 67(3): 523-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22194301
12.
Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV.
J Antimicrob Chemother
; 67(5): 1246-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294646
13.
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
J Infect Dis
; 203(11): 1629-36, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21592993
14.
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.
Clin Infect Dis
; 53(12): 1291-5, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22028438
15.
Noncirrhotic portal hypertension in HIV infection.
Curr Opin Infect Dis
; 24(1): 12-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21157331
16.
Directly acting antivirals against hepatitis C virus.
J Antimicrob Chemother
; 66(8): 1673-86, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21652618
17.
[Human immunodeficiency virus infection and viral hepatitis]. / Infección por virus de la inmunodeficiencia humana y hepatitis víricas.
Enferm Infecc Microbiol Clin
; 29(9): 691-701, 2011 Nov.
Artigo
em Espanhol
| MEDLINE | ID: mdl-21978797
18.
Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.
J Infect Dis
; 202(8): 1185-91, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812847
19.
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
Clin Infect Dis
; 51(10): 1209-16, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20964522
20.
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C.
J Antimicrob Chemother
; 65(3): 543-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032006